These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11414310)

  • 1. Disturbed synthesis of insulinlike growth factor I and its binding proteins may influence renal function changes in liver cirrhosis.
    Fernández-Rodriguez CM; Prada I; Andrade A; Moreiras M; Guitián R; Aller R; Lledó JL; Cacho G; Quiroga J; Prieto J
    Dig Dis Sci; 2001 Jun; 46(6):1313-20. PubMed ID: 11414310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone/insulin-like growth factor 1 axis alterations contribute to disturbed protein metabolism in cirrhosis patients after hepatectomy.
    Inaba T; Saito H; Inoue T; Han I; Furukawa S; Matsuda T; Ikeda S; Muto T
    J Hepatol; 1999 Aug; 31(2):271-6. PubMed ID: 10453940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of generation of growth hormone-stimulated insulin-like growth factor-I (IGF-I) and its binding protein-3 in patients with compensated and decompensated liver cirrhosis.
    Assy N; Hochberg Z; Enat R; Baruch Y
    Dig Dis Sci; 1998 Jun; 43(6):1317-21. PubMed ID: 9635625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum insulin like growth factor-1 (IGF-1) and insulin like growth factor binding protein-3 (IGFBP-3) levels in liver cirrhosis.
    Colakoğlu O; Taşkiran B; Colakoğlu G; Kizildağ S; Ari Ozcan F; Unsal B
    Turk J Gastroenterol; 2007 Dec; 18(4):245-9. PubMed ID: 18080921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis.
    Møller S; Juul A; Becker U; Flyvbjerg A; Skakkebaek NE; Henriksen JH
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1148-57. PubMed ID: 7536200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of circulating and regional growth hormone-binding protein in cirrhosis.
    Møller S; Fisker S; Becker U; Henriksen JH
    Metabolism; 2001 Nov; 50(11):1340-5. PubMed ID: 11699054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis.
    Kratzsch J; Blum WF; Schenker E; Keller E
    Exp Clin Endocrinol Diabetes; 1995; 103(5):285-91. PubMed ID: 8536056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre- and post-translational regulation of renal insulin-like growth factor binding protein-1 in insulin-deficient diabetes.
    Kaufman CR; Catanese VM
    J Investig Med; 1995 Apr; 43(2):178-86. PubMed ID: 7537614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arteriovenous shunting, hemodynamic changes, and renal sodium retention in liver cirrhosis.
    Fernández-Rodriguez CM; Prieto J; Zozaya JM; Quiroga J; Guitián R
    Gastroenterology; 1993 Apr; 104(4):1139-45. PubMed ID: 8462804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of insulin-like growth factor-I and insulin-like growth factor binding proteins during thioacetamide-induced liver cirrhosis in rats.
    Novosyadlyy R; Dargel R; Scharf JG
    Growth Horm IGF Res; 2005 Oct; 15(5):313-23. PubMed ID: 16098781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of alcohol and liver cirrhosis on the GH-IGF-I axis.
    Santolaria F; González-González G; González-Reimers E; Martínez-Riera A; Milena A; Rodgíguez-Moreno F; González-García C
    Alcohol Alcohol; 1995 Nov; 30(6):703-8. PubMed ID: 8679009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinsulinemia in preascitic cirrhosis: effects on systemic and renal hemodynamics, sodium homeostasis, forearm blood flow, and sympathetic nervous activity.
    Wong F; Logan A; Blendis L
    Hepatology; 1996 Mar; 23(3):414-22. PubMed ID: 8617419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.
    Donaghy A; Ross R; Gimson A; Hughes SC; Holly J; Williams R
    Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features.
    Pellecchia MT; Pivonello R; Monsurrò MR; Trojsi F; Longo K; Piccirillo G; Pivonello C; Rocco M; Di Somma C; Colao A; Tedeschi G; Barone P
    Eur J Neurol; 2010 May; 17(5):666-71. PubMed ID: 20002733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF status is altered by tamoxifen in patients with breast cancer.
    Campbell MJ; Woodside JV; Secker-Walker J; Titcomb A; Leathem AJ
    Mol Pathol; 2001 Oct; 54(5):307-10. PubMed ID: 11577172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal hemodynamics and the renin--angiotensin system in cirrhosis: relationship to sodium retention.
    Rosoff L; Williams J; Moult P; Williams H; Sherlock S
    Dig Dis Sci; 1979 Jan; 24(1):25-32. PubMed ID: 428287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating growth hormone and insulin-like growth factor-I in nonalcoholic liver cirrhosis with or without superimposed hepatocarcinoma: evidence of an altered circadian rhythm.
    Buzzelli G; Dattolo P; Pinzani M; Brocchi A; Romano S; Gentilini P
    Am J Gastroenterol; 1993 Oct; 88(10):1744-8. PubMed ID: 8213718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.